AstraZeneca PLC and The Medicines Company Announce Global Collaboration in Acute Ischemic Heart Disease

WILMINGTON, Del. & PARSIPPANY, N.J.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) and The Medicines Company (NASDAQ: MDCO) announced today a global collaboration for acute ischemic heart disease compounds.
Read the full story: BioSpace.com Featured News